1. Home
  2. BCAB vs EDRY Comparison

BCAB vs EDRY Comparison

Compare BCAB & EDRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • EDRY
  • Stock Information
  • Founded
  • BCAB 2007
  • EDRY 2018
  • Country
  • BCAB United States
  • EDRY Greece
  • Employees
  • BCAB N/A
  • EDRY N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • EDRY Marine Transportation
  • Sector
  • BCAB Health Care
  • EDRY Consumer Discretionary
  • Exchange
  • BCAB Nasdaq
  • EDRY Nasdaq
  • Market Cap
  • BCAB 28.6M
  • EDRY 31.7M
  • IPO Year
  • BCAB 2020
  • EDRY N/A
  • Fundamental
  • Price
  • BCAB $0.46
  • EDRY $11.11
  • Analyst Decision
  • BCAB Buy
  • EDRY
  • Analyst Count
  • BCAB 2
  • EDRY 0
  • Target Price
  • BCAB $5.00
  • EDRY N/A
  • AVG Volume (30 Days)
  • BCAB 990.6K
  • EDRY 6.1K
  • Earning Date
  • BCAB 03-25-2025
  • EDRY 02-13-2025
  • Dividend Yield
  • BCAB N/A
  • EDRY N/A
  • EPS Growth
  • BCAB N/A
  • EDRY N/A
  • EPS
  • BCAB N/A
  • EDRY N/A
  • Revenue
  • BCAB $11,000,000.00
  • EDRY $65,085,280.00
  • Revenue This Year
  • BCAB N/A
  • EDRY $34.61
  • Revenue Next Year
  • BCAB N/A
  • EDRY $15.93
  • P/E Ratio
  • BCAB N/A
  • EDRY N/A
  • Revenue Growth
  • BCAB N/A
  • EDRY 39.04
  • 52 Week Low
  • BCAB $0.43
  • EDRY $10.04
  • 52 Week High
  • BCAB $4.02
  • EDRY $24.84
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 23.28
  • EDRY 42.86
  • Support Level
  • BCAB $0.46
  • EDRY $11.20
  • Resistance Level
  • BCAB $0.49
  • EDRY $11.72
  • Average True Range (ATR)
  • BCAB 0.04
  • EDRY 0.43
  • MACD
  • BCAB 0.03
  • EDRY 0.08
  • Stochastic Oscillator
  • BCAB 27.98
  • EDRY 50.71

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About EDRY EuroDry Ltd.

EuroDry Ltd is a holding company. It is a provider of ocean-going transportation. The company owns and operates dry bulk carriers that transport bulks such as iron ore, coal, and grains, and minor bulks such as bauxite, phosphate, and fertilizers.

Share on Social Networks: